Literature DB >> 26923254

Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome.

Cécile M Yelnik1,2, Elizabeth Kozora3,4,5, Simone Appenzeller6.   

Abstract

Thrombotic manifestations of antiphospholipid syndrome (APS) are well known, and various non-stroke neuro-psychiatric manifestations (NPMs) have also been consistently described, but their place in APS remains unclear. Some syndromes, such as migraine or cognitive dysfunction, are frequently described in APS, whereas others, like seizure, multiple sclerosis-like symptoms, transverse myelitis, movement disorders, or psychiatric symptoms, are rarely found. Overlap with other autoimmune diseases, in particular with systemic lupus erythematosus, the lack of large sample size prospective studies, and discrepancies in antiphospholipid antibody (aPL) determinations complicate the study of the relationship between those disorders and aPL/APS. This review article aimed to summarize updated data on pathophysiologic, epidemiologic, and radiologic findings about non-stroke NPM described in primary APS and aPL-positive patients without overlap of other autoimmune diseases.

Entities:  

Keywords:  Antiphospholipid antibody; Antiphospholipid syndrome (APS); Autoimmunity; Neurological manifestations; Non-thrombotic manifestations; Systemic lupus erythematosus (SLE)

Mesh:

Year:  2016        PMID: 26923254     DOI: 10.1007/s11926-016-0568-x

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  104 in total

1.  Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients.

Authors:  Elizabeth Kozora; Doruk Erkan; Lening Zhang; Robert Zimmerman; Glendalee Ramon; Aziz M Ulug; Michael D Lockshin
Journal:  Clin Exp Rheumatol       Date:  2013-09-10       Impact factor: 4.473

Review 2.  The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features.

Authors:  Mirhelen M Abreu; Adriana Danowski; Denis G Wahl; Mary-Carmen Amigo; Maria Tektonidou; Marcelo S Pacheco; Norma Fleming; Vinicius Domingues; Savino Sciascia; Julia O Lyra; Michelle Petri; Munther Khamashta; Roger A Levy
Journal:  Autoimmun Rev       Date:  2015-01-29       Impact factor: 9.754

3.  Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study.

Authors:  G E Tietjen; M Day; L Norris; S Aurora; A Halvorsen; L R Schultz; S R Levine
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

4.  High association of anticardiolipin antibodies with psychosis.

Authors:  M Schwartz; M Rochas; B Weller; A Sheinkman; I Tal; D Golan; N Toubi; I Eldar; B Sharf; D Attias
Journal:  J Clin Psychiatry       Date:  1998-01       Impact factor: 4.384

Review 5.  Migraine, memory loss, and "multiple sclerosis ". Neurological features of the antiphospholipid (Hughes') syndrome.

Authors:  G R V Hughes
Journal:  Postgrad Med J       Date:  2003-02       Impact factor: 2.401

6.  Parkinsonism in a patient with antiphospholipid syndrome--case report and literature review.

Authors:  Yen-Chu Huang; Rong-Kuo Lyu; Sien-Tsong Chen; Yi-Chuan Chu; Yih-Ru Wu
Journal:  J Neurol Sci       Date:  2007-11-09       Impact factor: 3.181

7.  Obsessive-compulsive behavior as presenting symptom of primary antiphospholipid syndrome.

Authors:  Elke Van Roie; Veerle Labarque; Marleen Renard; Christel Van Geet; Loes Gabriëls
Journal:  Psychosom Med       Date:  2013-03-26       Impact factor: 4.312

8.  The pathogenesis of neural injury in animal models of the antiphospholipid syndrome.

Authors:  Aviva Katzav; Yehuda Shoenfeld; Joab Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

9.  Seizures in primary antiphospholipid syndrome: the relevance of smoking to stroke.

Authors:  Jozélio Freire de Carvalho; Sandra Gofinet Pasoto; Simone Appenzeller
Journal:  Clin Dev Immunol       Date:  2012-03-25

10.  Chorea associated with high titers of antiphospholipid antibodies in the absence of antiphospholipid antibody syndrome.

Authors:  Damoun Safarpour; Sarah Buckingham; Bahman Jabbari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-02-13
View more
  13 in total

1.  Autonomic neuropathy-in its many guises-as the initial manifestation of the antiphospholipid syndrome.

Authors:  Jill R Schofield
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

2.  Definition and treatment approach of non-criteria clinical manifestations of antiphospholipid syndrome.

Authors:  Ayten Yazıcı
Journal:  Eur J Rheumatol       Date:  2020-10

Review 3.  Neurologic Manifestations of Catastrophic Antiphospholipid Syndrome.

Authors:  Rafid Mustafa
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-30       Impact factor: 6.030

Review 4.  Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria.

Authors:  Medha Barbhaiya; Stephane Zuily; Yasaman Ahmadzadeh; Mary-Carmen Amigo; Tadej Avcin; Maria Laura Bertolaccini; D Ware Branch; Guilherme de Jesus; Katrien M J Devreese; Camille Frances; David Garcia; Francis Guillemin; Steven R Levine; Roger A Levy; Michael D Lockshin; Thomas L Ortel; Surya V Seshan; Maria Tektonidou; Denis Wahl; Rohan Willis; Ray Naden; Karen Costenbader; Doruk Erkan
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-09-02       Impact factor: 5.178

5.  Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome.

Authors:  R Weiss; A Bitton; L Nahary; M T Arango; I Benhar; M Blank; Y Shoenfeld; J Chapman
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 6.  Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy.

Authors:  Thomas Fleetwood; Roberto Cantello; Cristoforo Comi
Journal:  Front Neurol       Date:  2018-11-26       Impact factor: 4.003

7.  Anaesthetic considerations for patients with antiphospholipid syndrome undergoing non-cardiac surgery.

Authors:  Jae Won Kim; Tae Woo Kim; Keon Hee Ryu; Sun Gyoo Park; Chang Young Jeong; Dong Ho Park
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

8.  Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome.

Authors:  Ilan Volkov; Luciana Seguro; Elaine P Leon; László Kovács; Dirk Roggenbuck; Peter Schierack; Boris Gilburd; Andrea Doria; Maria G Tektonidou; Nancy Agmon-Levin
Journal:  Auto Immun Highlights       Date:  2020-05-15

Review 9.  Immune-Mediated Disorders Affecting the Spinal Cord and the Spine.

Authors:  Gina S Perez Giraldo; Jorge G Ortiz Garcia
Journal:  Curr Neurol Neurosci Rep       Date:  2021-01-03       Impact factor: 5.081

Review 10.  Ischemic Stroke in the Young.

Authors:  Samuel A Berkman; Shlee S Song
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.